"glorious CEO"
not sure as to why the sarcasm Purple?
Wayne Paterson has been at the helm of the company which has overseen the design, development and delivery (64 patients) of the best and most effective TAVR device in the history of TAVR....
And it's highly plausible that the DurAVR will, in time, take a vast majority of market share. Excellent work by Wayne.
As to the recent sell off, what does that have to do with Wayne? Not really sure as to the point of your post?
Ann: AGM Chairman and CEO Presentation, page-10
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.93 |
Change
-0.290(2.37%) |
Mkt cap ! $252.1M | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.22 | $11.21 | $199.1K | 17.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 577 | $11.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.93 | 131 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |